Cargando…

Comparison of live and fixed cell-based assay performance: implications for the diagnosis of MOGAD in a low-middle income country

BACKGROUND: Though considered optimal, live cell-based assay (LCBA) is often unavailable for the diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD) in resource-poor regions. This study was undertaken to determine the agreement between LCBA and the widely available...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandit, Lekha, D’Cunha, Anitha, Malli, Chaithra, Sudhir, Akshatha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495565/
https://www.ncbi.nlm.nih.gov/pubmed/37705970
http://dx.doi.org/10.3389/fimmu.2023.1252650